Press Releases

Qteros, Inc., the developer of a unique consolidated bioprocessing platform for low-cost production of cellulosic biofuels, today announced that the Company’s Senior Vice President and Chief Technology Officer, Kevin Gray, Ph.D., will participate in a panel discussion at BioMass Magazine’s Northeast BIOMASS Conference and Expo.

Dr. Gray’s presentation entitled, “Development of a Low-cost Biomass Conversion Process using the Micro-organism Clostridium phytofermentans” will be delivered as part of the panel discussion, “Cutting-Edge Conversion Approaches: Breakthroughs in Biorefining.” The panel discussion will occur on Thursday, August 5, 2010 at 1:30pm EST at Westin Copley Place in Boston, Massachusetts.

Dr. Gray leads research and development for Qteros and establishes technical standards for the Company’s product development initiatives. Prior to joining Qteros, Dr. Gray was Senior Director of Biofuels Research and Development at Verenium Corporation in San Diego, California. Dr. Gray holds a Ph.D. in chemistry from Texas Tech University and a B.S. in zoology from Duke University. He has been a co-author on 40 peer-reviewed scientific articles and is a co-inventor on 22 patents and patent applications.

About Qteros, Inc.

Qteros’ mission is to accelerate the global commercialization of large-scale, low-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with strategic partners, Qteros expects to rapidly scale its highly-efficient, low-cost Consolidated Bioprocessing (CBP) Platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC, and Valero Energy Corporation.

Qteros, Inc., a leading developer of next-generation technology solutions for the biofuels industry based on its unique Q Microbe® platform, today announced its plans to participate in several conferences throughout June.

John McCarthy, President and Chief Executive Officer of Qteros, will provide a company overview at the Credit Suisse Future of Energy Conference on Thursday, June 3, 2010 at 3:15pm EST at the Mandarin Oriental Hotel in Washington, DC.

On June 9, 2010, Mr. McCarthy will present at Lazard Capital Markets 2nd Annual Alternative Energy Investor Summit at the Mandarin Oriental Hotel in New York, NY. Mr. McCarthy will present on the “Alternative Fuels” panel at 3:15 pm EST.

On Wednesday, June 16, 2010, at 3:30 pm CST Qteros Vice President of Commercial Development, Mick Sawka, will present and participate in a panel discussion at the Fuel Ethanol Workshop taking place at America’s Center in St. Louis, MO. Mr. Sawka’s presentation entitled, “Consolidated Bio-processing using Clostridium phytofermentans” will be delivered as part of the panel discussion, “Cellulosic Ethanol: Paving Pathways to Proficiency.”

Kevin Gray, Ph.D., SVP & Chief Technology Officer for Qteros, will present at the BIO World Congress on Industrial Biotechnology and Bioprocessing. Dr. Gray will chair and present on a panel entitled, “Advances in Fermentation.” The panel will be held on Tuesday, June 29, 2010 at 9:00 am EST at the Gaylord National Resort and Convention Center in Washington, DC.

About Qteros, Inc.

Qteros is committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The Company is currently in the process of scaling up a unique microbial solution for the highly-efficient and cost-effective conversion of non-food biomass into clean transportation fuel. The Company’s patented Q Microbe® system converts a wide array of cellulosic biomass directly into ethanol in a single streamlined process, thereby consolidating enzymatic hydrolysis and fermentation, largely eliminating costly exogenous enzymes and associated pretreatments, and greatly simplifying the entire production process. This process is commonly referred to as consolidated bio-processing. Qteros’ scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world’s growing energy needs. Qteros has been funded by some of the leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, visit www.Qteros.com.

Qteros, Inc., a leading developer of next-generation technology solutions for the biofuels industry based on its unique Q Microbe® platform, today announced that the Company’s President and Chief Executive Officer, John McCarthy, will serve as a panel member for “The Critical Path to Advanced Biofuel Commercialization” discussion to be held at the 2010 BIO Annual Convention.

The event will occur on Tuesday, May 4, 2010 from 2:00 – 3:30p.m. CDT at McCormick Place, Chicago, IL, in the South Bldg., Room S402B, Level 4.

About Qteros, Inc.

Qteros is committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The Company is currently in the process of scaling up a unique microbial solution for the highly-efficient and cost-effective conversion of non-food biomass into clean transportation fuel. The Company’s patented Q Microbe® system converts a wide array of cellulosic biomass directly into ethanol in a single streamlined process, thereby consolidating enzymatic hydrolysis and fermentation, largely eliminating costly exogenous enzymes and associated pretreatments, and greatly simplifying the entire production process. This process is commonly referred to as consolidated bio-processing. Qteros’ scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world’s growing energy needs. Qteros has been funded by some of the leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP Technology Ventures, Soros Fund Management LLC, and Valero Energy Corporation.

Jef Sharp Continues Role as Qteros Board Member

MARLBOROUGH, MASS., April 26, 2010—Qteros, Inc., a leading developer of next-generation technology solutions for the biofuels industry based on its unique Q Microbe™ platform, today announced the appointment of Susan Hager as Vice President of Corporate Communications and Government Affairs. In this role, Ms. Hager will report directly to John McCarthy, President and Chief Executive Officer. Jef Sharp, Senior Vice President of Corporate Communications and Government Affairs, Director and a member of the Qteros founding group, will continue to serve the Company as a member of Qteros’ Board of Directors.

Ms. Hager will be responsible for leading all communications and government-related initiatives for the Company, with an emphasis on building and enhancing Qteros’ unique positioning and brand within the industry. Ms. Hager’s career spans more than 16 years, and has focused on developing results-driven communications campaigns for a broad portfolio of unique life science companies within both the private and public sectors. Her expertise includes corporate communications, investor relations, and media relations in support of complex product marketing and commercialization initiatives. Ms. Hager has considerable experience in advocacy relations and government affairs, specifically in developing and implementing communications programs to align influential advocacy groups and rally government support for various agency approvals and funding. … more

Qteros, Inc., and the University of Massachusetts Amherst announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,682,811 titled “Systems and Methods for Producing Biofuels and Related Materials” describing the novel creation of products, including biofuels, through the fermentation of biomass by a unique, naturally-occurring anaerobic microorganism.

The patent is based on the novel Q Microbe™ (Clostridium phytofermentans), discovered by UMass Amherst microbiologists Professor Susan Leschine and Research Associate Thomas Warnick. Qteros, the exclusive licensee of the patent, has demonstrated that their Q Microbe™ technology offers ethanol producers significant cost reductions by streamlining the biomass-conversion process, commonly referred to as “consolidated bio-processing” (CBP).

“Integration of our unique Q Microbe™ technology into a cellulosic ethanol plant design allows producers the opportunity to dramatically reduce the capital and operating costs associated with a biomass-to-ethanol process,” states Kevin A. Gray, PhD, Senior Vice President and Chief Technology Officer of Qteros. According to Gray, “While traditional cellulosic ethanol processes require numerous production steps, including the addition of costly exogenous enzymes, use of the Q Microbe™ lowers costs by simultaneously hydrolyzing polysaccharides into simple sugars and fermenting all of these sugars into desirable products in a single-tank operation.” … more

Qteros, Inc., a leading developer of second-generation technology solutions for the biofuels industry based on its unique Q Microbe™ platform, announced today that Mick Sawka has joined the company as Vice President, Business Development, to help accelerate the company’s technology and commercial initiatives in the worldwide cellulosic ethanol marketplace.

Mr. Sawka’s 19-year experience in the specialty chemicals industry includes negotiating and leading numerous large-scale strategic partnerships, alliances, and acquisitions as well as complex product introductions throughout the world. Additionally, Sawka has been responsible for the development of numerous technology platforms and associated strategic business plans within both development-stage and large-scale specialty chemical organizations.

Mr. Sawka joins Qteros from Microbia, Inc. where he led business development efforts for this developer of unique bio-based specialty chemicals directed at large-scale industrial applications. Prior to Microbia, Mr. Sawka spent six years at Cabot Corporation, most recently serving as Director of New Business Development and R&D for Cabot’s Performance Products Business Group. Prior to Cabot, Sawka spent 11 years at 3M in various senior level business and product development positions throughout the company. Mr. Sawka holds a BS in Chemical Engineering from Stanford University, an MS in Chemical Engineering from MIT (including assignments in Dr. Robert Langer’s lab), and a Masters in International Management from The University of St. Thomas in St. Paul, Minnesota.

“Having worked closely with Mick at Microbia, I’m thrilled to have him join us to help at this important stage of our development and believe he brings the kind of energy, industry experience, and business creativity we need at Qteros to help catalyze our strategic corporate development efforts”, stated John McCarthy, President and CEO of Qteros.  “Mick’s experience and success helping lead innovative product development within large-scale industrial chemicals companies will bring a great complement to our team as we accelerate the development of important industrial partnerships for Qteros.”

“Qteros is a dynamic organization with a truly disruptive technology platform, and I am thrilled to have the opportunity to help build the partnerships that will transform Qteros’ scientific achievements into commercial reality within the emerging worldwide biofuels industry,” stated Sawka. … more

Qteros, Inc., a leading developer of second-generation technology solutions for the biofuels industry based on its unique Q Microbe ™ platform, announced today that John McCarthy has joined the company as President and Chief Executive Officer  to accelerate the company’s technology and commercial initiatives in the worldwide cellulosic ethanol marketplace.

Mr. McCarthy’s 18-year experience includes managing the transformational growth of numerous leading life science and bio-based chemical companies into high-value commercial entities. He has raised over $1 billion of capital in the private and public markets, and developed and executed numerous complex and large-scale strategic corporate partnerships.

Mr. McCarthy joins Qteros from Microbia, Inc. where he served as Chief Business Officer of this developer of unique bio-based specialty chemicals for large-scale industrial applications. Prior to Microbia, Mr. McCarthy was Executive Vice President for publicly-traded Verenium Corporation, a pioneering leader in the development and commercialization of cellulosic ethanol and specialty enzymes.  At Verenium, McCarthy served as the chief architect of the company’s growth from a small privately-held business into a publicly-traded leader in the industry through the successful merger and integration of Celunol and Diversa and the subsequent creation and execution of the industry’s precedent-setting strategic corporate partnership with BP plc. … more

Employees to use root-enhanced, native species to enhance greenhouse gas reduction on the local level … more

… more

… more